|
SeffinDrug - Seffin The trade name of the product as shown on the labeling.
Dosage -
INJECTABLE; INJECTION
Active Ingredient(s) -
Cephalothin Sodium
Strength -
EQ 2GM BASE/VIAL
Applicant -
GLAXOSMITHKLINE
New Drug Application (NDA) Number -
062435
Product Number -
002
Therapeutic Equivalence (TE) Code -
Approval Date -
Nov 15, 1983
Reference Listed Drug (RLD) -
No
Type -
DISCN
Applicant Full Name -
Glaxosmithkline
Seffin
Keflin Eq 20gm Base/vial Injectable; Injection
Keflin Eq 2gm Base/vial Injectable; Injection Keflin Eq 4gm Base/vial Injectable; Injection Keflin In Plastic Container Eq 1gm Base/vial Injectable; Injection Keflin In Plastic Container Eq 2gm Base/vial Injectable; Injection Seffin Eq 10gm Base/vial Injectable; Injection Seffin Eq 1gm Base/vial Injectable; Injection Seffin Eq 2gm Base/vial Injectable; Injection Cephalothin Sodium W/ Sodium Chloride In Plastic Container Eq 40mg Base/ml Injectable; Injection Keflin Eq 1gm Base/vial Injectable; Injection NewDrugInformation |